Skip to main content
OpenTrials
Completed

NCT Number: NCT07387237

Multigene Germline Panel Testing in Gastric Cancer Patients in Portugal

Multigene germeline panel test in gastric cancer patients

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Unidade Local de Saúde do Alto Alentejo

Portalegre, Portugal

About this study

We conducted a retrospective observational study including 51 patients with histologically confirmed gastric cancer who underwent MGPT between 2020 and 2025. Genetic testing was performed using validated 15 or 30 gene panels. Clinical, pathological, and survival data were retrieved from medical records.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Eligible participants were adults (≥18 years) with histologically confirmed gastric adenocarcinoma who underwent MGPT between 2020 and 2025;
  • Ability to understand Portuguese and/or English;
  • Ability to provide valid informed consent.

Exclusion criteria

  • All patients who met eligibility and inclusion criteria were included in the study;
  • Patients without a definitive genetic report or with incomplete clinical data for key study variables were excluded.

Treatment and study plan

Primary outcomes

  1. MGPT result

    Time frame: 5 years

    positive vs negative

Sponsors and collaborators

Lead sponsor

Unidade Local De Saúde Do Norte Alentejano

Other

Registry information

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Feb 4, 2026
Registry last updated
Feb 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.